Abbasi R, Nejati V, Rezaie J (2024) Exosomes biogenesis was increased in metformin-treated human ovary cancer cells; possibly to mediate resistance. Cancer Cell Int 24(1):137. https://doi.org/10.1186/s12935-024-03312-6
Article CAS PubMed PubMed Central Google Scholar
Adzhubei I, Jordan DM, Sunyaev SR (2013) Predicting functional effect of human missense mutations using PolyPhen-2. Curr Protocol Hum Gen 76(1):7–20. https://doi.org/10.1002/0471142905.hg0720s76
Ajam-Hosseini M, Akhoondi F, Doroudian M (2023) Nano basedoncolytic viruses for cancer therapy. Crit Rev Oncol Hematol 185:103980. https://doi.org/10.1016/j.critrevonc.2023.103980
Almohammai A, Rahbarghazi R, Keyhanmanesh R, Rezaie J, Ahmadi M (2021) Asthmatic condition induced the activity of exosome secretory pathway in rat pulmonary tissues. J Inflamm 18:1–9. https://doi.org/10.1186/s12950-021-00275-7
Altıntaş O, Saylan Y (2023) Exploring the versatility of exosomes: a review on isolation, characterization, detection methods, and diverse applications. Anal Chem 95(44):16029–16048. https://doi.org/10.1021/acs.analchem.3c02224
Anzalone AV, Koblan LW, Liu DR (2020) Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors. Nat Biotech 38(7):824–844. https://doi.org/10.1038/s41587-020-0561-9
Azhdari MH, Goodarzi N, Doroudian M, MacLoughlin R (2022) Molecular insight into the therapeutic effects of stem cell-derived exosomes in respiratory diseases and the potential for pulmonary delivery. Int J Molec Sci 23(11):6273. https://doi.org/10.3390/ijms23116273
Bala S, Marcos M, Kodys K, Csak T, Catalano D, Mandrekar P, Szabo G (2011) Up-regulation of microRNA-155 in macrophages contributes to increased tumor necrosis factor α (TNFα) production via increased mRNA half-life in alcoholic liver disease. J Biol Chem 286(2):1436–1444. https://doi.org/10.1074/jbc.M110.145870
Article CAS PubMed Google Scholar
Barrangou R, Fremaux C, Deveau H, Richards M, Boyaval P, Moineau S, Romero DA, Horvath P (2007) CRISPR provides acquired resistance against viruses in prokaryotes. Science 315(5819):1709–1712. https://doi.org/10.1126/science.1138140
Article CAS PubMed Google Scholar
Batrakova EV, Kim MS (2015) Using exosomes, naturally-equipped nanocarriers, for drug delivery. J Control Rel 219:396–405. https://doi.org/10.1016/j.jconrel.2015.07.030
Berezhna SY, Supekova L, Sever MJ, Schultz PG, Deniz AA (2011) Dual regulation of hepatitis C viral RNA by cellular RNAi requires partitioning of Ago2 to lipid droplets and P-bodies. Rna 17(10):1831–1845. https://doi.org/10.1261/rna.2523911
Article CAS PubMed PubMed Central Google Scholar
Calabrese R, Capriotti E, Fariselli P, Martelli PL, Casadio R (2009) Functional annotations improve the predictive score of human disease-related mutations in proteins. Hum Mutat 30(8):1237–1244. https://doi.org/10.1002/humu.21047
Article CAS PubMed Google Scholar
Carugo O, Pongor S (2001) A normalized root-mean-spuare distance for comparing protein three-dimensional structures. Protein Sci 10(7):1470–1473. https://doi.org/10.1110/ps.690101
Article CAS PubMed PubMed Central Google Scholar
Cecchin R, Troyer Z, Witwer K, Morris KV (2023) Extracellular vesicles: The next generation in gene therapy delivery. Molec Ther 31(5):1–6. https://doi.org/10.1016/j.ymthe.2023.01.021
Chen Q, Shen Y, Zheng J (2021) A review of cystic fibrosis: Basic and clinical aspects. Anim Models Exp Med 4(3):220–232. https://doi.org/10.1002/ame2.12180
Chen Z, Xiong M, Tian J, Song D, Duan S, Zhang L (2024) Encapsulation and assessment of therapeutic cargo in engineered exosomes: a systematic review. J Nanobiotechnol 22(1):1–19. https://doi.org/10.1186/s12951-023-02259-6
Dinh PUC, Paudel D, Brochu H, Popowski KD, Gracieux MC, Cores J, Huang K, Hensley MT, Harrell E, Vandergriff AC, George AK (2020) Inhalation of lung spheroid cell secretome and exosomes promotes lung repair in pulmonary fibrosis. Nat Mommun 11(1):1064. https://doi.org/10.1038/s41467-020-14344-7
Dong B, Wang C, Zhang J, Zhang J, Gu Y, Guo X, Zuo X, Pan H, Hsu ACY, Wang G, Wang F (2021) Exosomes from human umbilical cord mesenchymal stem cells attenuate the inflammation of severe steroid-resistant asthma by reshaping macrophage polarization. Stem Cell Res Ther 12:1–17. https://doi.org/10.1186/s13287-021-02244-6
Doroudian M, Zanganeh S, Abbasgholinejad E, Donnelly SC (2023a) Nanomedicine in lung cancer immunotherapy. Front Bioeng Biotechnol 11:1144653. https://doi.org/10.3389/fbioe.2023.1144653
Article PubMed PubMed Central Google Scholar
Doroudian M, Armstrong ME, Donnelly SC (2023b) Nano-based therapies for acute and chronic lung diseases. In: Biotechnology applied to inflammatory diseases: Cellular mechanisms and nanomedicine, pp 271–286. https://doi.org/10.1007/978-981-19-8342-9_12
Doyle LM, Wang MZ (2019) Overview of extracellular vesicles, their origin, composition, purpose, and methods for exosome isolation and analysis. Cells 8(7):727. https://doi.org/10.3390/cells8070727
Article CAS PubMed PubMed Central Google Scholar
Eltoukhy AA, Chen D, Veiseh O, Pelet JM, Yin H, Dong Y, Anderson DG (2014) Nucleic acid-mediated intracellular protein delivery by lipid-like nanoparticles. Biomaterials 35(24):6454–6461. https://doi.org/10.1016/j.biomaterials.2014.04.014
Article CAS PubMed PubMed Central Google Scholar
Eulalio A, Behm-Ansmant I, Schweizer D, Izaurralde E (2007) P-body formation is a consequence, not the cause, of RNA-mediated gene silencing. Molec Cell Biol 27(11):3970–3981. https://doi.org/10.1128/MCB.00128-07
Article CAS PubMed PubMed Central Google Scholar
Gao Z-S, Zhang C-J, Xia N, Tian H, Li D-Y, Lin J-Q, Xi-Fan Mei CW (2021) Berberine-loaded M2 macrophage-derived exosomes for spinal cord injury therapy. Acta Biomater 126:211–23. https://doi.org/10.1016/j.actbio.2021.03.018
Article CAS PubMed Google Scholar
Gee P, Lung MS, Okuzaki Y, Sasakawa N, Iguchi T, Makita Y, Hozumi H, Miura Y, Yang LF, Iwasaki M, Wang XH (2020) Extracellular nanovesicles for packaging of CRISPR-Cas9 protein and sgRNA to induce therapeutic exon skipping. Nat Commun 11(1):1334. https://doi.org/10.1038/s41467-020-14957-y
Article CAS PubMed PubMed Central Google Scholar
Ghasempour E, Hesami S, Movahed E, Keshel SH, Doroudian M (2022) Mesenchymal stem cell-derived exosomes as a new therapeutic strategy in the brain tumors. Stem Cell Res Ther 13(1):527. https://doi.org/10.1186/s13287-022-03212-4
Article CAS PubMed PubMed Central Google Scholar
Givens BE, Naguib YW, Geary SM, Devor EJ, Salem AK (2018) Nanoparticle-based delivery of CRISPR/Cas9 genome-editing therapeutics. AAPS J 20:1–22. https://doi.org/10.1208/s12248-018-0267-9
Gonçalves GAR, de Paiva R, M. A. (2017) Gene therapy: advances, challenges and perspectives. Einstein 15(3):369–375. https://doi.org/10.1590/S1679-45082017RB4024
Article PubMed PubMed Central Google Scholar
Gong C, Tian J, Wang Z, Gao Y, Wu X, Ding X, Qiang L, Li G, Han Z, Yuan Y, Gao S (2019) Functional exosome-mediated co-delivery of doxorubicin and hydrophobically modified microRNA 159 for triple-negative breast cancer therapy. J Nanobiotechnol 17:1–18. https://doi.org/10.1186/s12951-019-0526-7
Gori JL, Hsu PD, Maeder ML, Shen S, Welstead GG, Bumcrot D (2015) Delivery and specificity of CRISPR/Cas9 genome editing technologies for human gene therapy. Hum Gene Ther 26(7):443–51. https://doi.org/10.1089/hum.2015.074
Article CAS PubMed Google Scholar
Gutschner T, Hämmerle M, Pazaitis N, Bley N, Fiskin E, Uckelmann H, Heim A, Groβ M, Hofmann N, Geffers R, Skawran B (2014) Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) is an important protumorigenic factor in hepatocellular carcinoma. Hepatology 59(5):1900–1911. https://doi.org/10.1002/hep.26997
留言 (0)